Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By IPO Scoop (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

The IPO Buzz: AI Platform CoreWeave (CRWV Proposed) on the IPO Marquee

% of readers think this story is Fact. Add your two cents.


CoreWeave, Inc. (CRWV Proposed), an NVIDIA-backed AI platform company that runs 32 data centers, is the big name on this week’s IPO Calendar. Livingston, N.J.-based CoreWeave’s IPO totals 49.0 million shares – with 47.18 million shares offered by CoreWeave and 1.82 million shares offered by the selling stockholders – at a price range of $47.00 to $55.00 to raise $2.5 billion – if priced at the $51.00 mid-point of the range.  CoreWeave would have a market cap of $24.1 billion – assuming mid-point pricing at $51.00. Morgan Stanley, J.P. Morgan and Goldman Sachs are the joint lead book-runners.  The book-running team includes another eight investment banks. The co-managers’ lineup consists of another seven investment banks. CoreWeave – the largest IPO of the year so far – tops this week’s IPO Calendar of $2.6 billion in deals with pricing dates – and another IPO that may price sometime this week. This week’s IPOs include Epsium Enterprise (EPSM), a Macau-based liquor importer and wholesaler, with D. Boral Capital as the sole book-runner, as well as WF International, the parent of a Chinese HVAC company, with The Benchmark Company and Axiom as joint book-runners, and UY Scuti Acquisition, a SPAC IPO, with the Maxim Group as the sole book-runner. A NASDAQ direct listing by a brain cancer-focused biotech, NeOnc Technologies Holdings Inc., is also in the lineup. Another small IPO, LogProStyle (LGPS), a Japanese real estate company, was priced Monday night, March 24, 2025, for trading Tuesday, March 25; Spartan Capital was the sole book-runner. CoreWeave, NVIDIA and OpenAI Founded in 2017, CoreWeave, Inc. launched its CoreWeave Cloud Platform in 2020. The company said its “CoreWeave Cloud Platform consists of our proprietary software and cloud services that deliver the software and software intelligence needed to manage complex AI infrastructure at scale.” As of Dec. 31, 2024, “our 32 data centers were running more than 250,000 GPUs in total, and were supported by more than 360 MW of active power. Our total contracted power extends to approximately 1.3 GW as of December 31, 2024, which we expect to roll out over the coming years.” NVIDIA Corp., a pioneer of GPU-driven computing, is both a CoreWeave customer and a principal shareholder. NVIDIA has a 6 percent pre-IPO stake in CoreWeave. Other principal shareholders include Magnetar Financial, a hedge fund manager, with a 34.5 percent pre-IPO stake, and entities affiliated with Fidelity, with a 7.56 percent pre-IPO stake, the prospectus said. CoreWeave announced on March 10, 2025, that it had signed an $11.9 billion contract with OpenAI – covering a five-year period – to provide OpenAI with AI infrastructure, as Reuters had previously reported exclusively. In the prospectus, CoreWeave said that immediately after the IPO’s closing, it “will issue to OpenAI, in accordance with the terms of our master services agreement with OpenAI and pursuant to a stock issuance agreement with OpenAI, a number of shares of our Class A common stock equal to $350.0 million valued at a price per share equal to the initial public offering price.” CoreWeave is not profitable, according to financial statements in the prospectus. For the year that ended Dec. 31, 2024, CoreWeave reported a net loss of  $863.45 million on revenue of about $1.92 billion. (For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com  website.) Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board. To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message. Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions. Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the  shifting of investor interest in the IPO. The information offered is taken from sources we


Source: https://www.iposcoop.com/the-ipo-buzz-ai-platform-coreweave-crwv-proposed-on-the-ipo-marquee/



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.